Divi's Laboratories Explained

Divi's Laboratories Limited
Logo Alt:Divi's Laboratories' logo
Former Name:Divi's Research Centre
Type:Public
Isin:INE361B01024
Industry:Pharmaceuticals
Services:Custom synthesis
Revenue Year:2022
Income Year:2022
Net Income Year:2022
Assets Year:2022
Equity Year:2022
Hq Location:Divi Towers, Cyber Hills, Gachibowli
Hq Location City:Hyderabad, Telangana
Hq Location Country:India
Products:Active Pharmaceutical Ingredients
Nutraceuticals
Num Employees:13,884
Num Employees Year:2020
Footnotes:[1] [2] [3] [4]

Divi's Laboratories Limited is an Indian multinational pharmaceutical company and producer of active pharmaceutical ingredients (APIs) and intermediates, headquartered in Hyderabad.[5] [6] [2] [7] The company manufactures and custom synthesizes generic APIs, intermediates.[8] [9] The company also manufactures and supplies nutraceutical ingredients through its subsidiary, Divi's Nutraceuticals. Divi's Laboratories is India's fourth largest publicly listed pharmaceutical company by market capitalization.[10]

History

The company initially started developing commercial processes for the manufacturing of APIs and intermediates. Divi's Research Centre changed its name to Divi's Laboratories Limited in 1994 to signal its intent to enter the API and intermediates manufacturing industry.[11] Following this, the company established its first Manufacturing facility in 1995 at Choutuppal, Telangana.[1] In 2002, the company's second manufacturing facility commenced operations at Chippada near Visakhapatnam.[1]

The company went public with its initial public offering (IPO) on 17 February 2003.[12] [11] In 2010, the company established a research centre in Hyderabad.[1]

Products and services

Active pharmaceutical ingredients (APIs) and intermediates

Divi's Laboratories has between 60 and 85% global market share in generic naproxen, dextromethorphan and gabapentin APIs.[13] The company currently has between 20 and 30% global market share in pregabalin and methylamine APIs.[13] The company's API production is backwards integrated.[14]

Custom synthesis

Divi's Laboratories custom synthesis division provides contract development and manufacturing (CDMO) services and contract research and manufacturing services (CRAMS).[14] The company's clients include 6 of the top 10 largest multinational pharmaceutical companies.[15]

Nutraceuticals

Divi's Nutraceuticals is a subsidiary of Divi's Laboratories, and manufacturers and supplies over 80 forms of carotenoids and vitamins.[16] Divi's Nutraceuticals was founded in 2006 as a subsidiary of Divi's Laboratories.

Facilities

The company has three manufacturing facilities and three R&D centres across India:[1]

Manufacturing

Notes and References

  1. Web site: Laboratories. Divi's. Annual Report. live. https://web.archive.org/web/20201018134305/https://www.divislabs.com/wp-content/uploads/2020/09/30th-Divi-Annual-Report.pdf. 18 October 2020. divislabs.com.
  2. Web site: Divi's Laboratories Ltd Company profile. live. https://web.archive.org/web/20201018134310/https://www.bloomberg.com/profile/company/DIVI:IN. 18 October 2020. 2020-09-15. Bloomberg L.P..
  3. Web site: Latest Shareholding Pattern - Divi's Laboratories Ltd.. 2020-09-15. trendlyne.com. 18 October 2020. https://web.archive.org/web/20201018134307/https://trendlyne.com/equity/share-holding/336/DIVISLAB/latest/divi-s-laboratories-ltd/. live.
  4. Web site: Laboratories. Divi's. Subsidiary Financials. live. https://web.archive.org/web/20201018134305/https://www.divislabs.com/wp-content/uploads/2020/08/Subsidiary-Financials-2020.pdf. 18 October 2020. divislabs.com.
  5. Web site: Company Profile-DIVIS LAB. 2020-09-15. Dynamic Levels. en-US. 18 October 2020. https://web.archive.org/web/20201018134310/https://stock-financials.valuestocks.in/en/divis-lab-company-profile. live.
  6. Web site: Company Profile for Divi's Laboratories Ltd. 2020-09-15. Reuters. 18 October 2017. https://web.archive.org/web/20171018154537/http://in.reuters.com/finance/stocks/company-profile/DIVI.BO. dead.
  7. Web site: DIVI'S LABORATORIES LIMITED - Company, directors and contact details Zauba Corp. 2020-09-15. www.zaubacorp.com. 18 October 2020. https://web.archive.org/web/20201018134313/https://www.zaubacorp.com/company/DIVI-S-LABORATORIES-LIMITED/L24110TG1990PLC011854. live.
  8. Web site: Top API Manufacturing Company In Hyderabad, India & World DivisLabs. 2020-09-15. Divis Laboratories World’s largest API manufacturing facility. en-US. 12 August 2020. https://web.archive.org/web/20200812025954/https://www.divislabs.com/api-manufacturing-company/. live.
  9. Web site: Bradstreet. Dun. Divi's Laboratories company profile. dnb.com. 18 October 2020. https://web.archive.org/web/20201018134332/https://www.dnb.com/business-directory/company-profiles.divis_laboratories_limited.344527b03327427e0ce523821ee82d40.html. live.
  10. News: Top Pharmaceuticals & Drugs Stocks in India by Market Capitalisation . 15 February 2023 . www.moneycontrol.com . en . 13 January 2023 . https://web.archive.org/web/20230113195129/https://www.moneycontrol.com/stocks/marketinfo/marketcap/bse/pharmaceuticals-drugs.html . live .
  11. Web site: Divis Laboratories > Company History > Pharmaceuticals > Company History of Divis Laboratories - BSE: 532488, NSE: DIVISLAB. 2020-09-17. moneycontrol.com. en. 6 June 2020. https://web.archive.org/web/20200606223407/https://www.moneycontrol.com/company-facts/divislaboratories/history/DL03. live.
  12. Web site: 2003-02-11. Divis Labs Fixes Rs 130 Per Share As Floor Price For IPO. 2020-09-18. The Financial Express. en-US. 17 March 2018. https://web.archive.org/web/20180317125855/http://www.financialexpress.com/archive/divis-labs-fixes-rs-130-per-share-as-floor-price-for-ipo/72906/. live.
  13. Web site: Khandekar . Siddhant . Shah . Mitesh . Agarwal . Sudarshan . 30 May 2021 . Divi's Laboratories (DIVLAB) . 16 May 2022 . ICICI Direct . 1 . 12 October 2022 . https://web.archive.org/web/20221012163918/https://www.icicidirect.com/mailimages/IDirect_DivisLab_Q4FY21.pdf . live .
  14. Web site: Sonavane . Ravindra N. . 2020-08-10 . Divi's Labs beats drugmakers to become India's 2nd most valuable pharma company . 2022-05-16 . mint . en . 15 August 2020 . https://web.archive.org/web/20200815210106/https://www.livemint.com/market/mark-to-market/divi-s-labs-share-price-rises-65-becomes-2nd-most-valuable-pharma-company-11597036374437.html . live .
  15. Web site: Jauhari . Ujjval . 2021-02-08 . Divi's Labs' Dec quarter show is strong but stock remains pricey . 2022-05-16 . mint . en . 6 April 2023 . https://web.archive.org/web/20230406115914/https://www.livemint.com/market/mark-to-market/divis-laboratories-q3-show-is-strong-but-stock-remains-pricey-11612789870282.html . live .
  16. Web site: Divis Nutraceuticals . 2021-09-14 . Press Release: Divi's Nutraceuticals launches CaroNat for natural food and beverage coloration . 2022-07-27 . Divi's Nutraceuticals . en-US.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Divi's Laboratories".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.